Letters Gender dysphoria

Author’s reply to Hawkins

BMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j4168 (Published 12 September 2017) Cite this as: BMJ 2017;358:j4168
  1. James Barrett, lead clinician
  1. Charing Cross Gender Identity Clinic, London, UK
  1. JBarrett2{at}tavi-port.nhs.uk

In answer to Hawkins,12 long term treatment of people assigned male at birth with oestrogens at a dose sufficient to give typically premenopausal oestrogen concentrations slightly raises their risk of thromboembolic disease. It changes from the risk …

View Full Text

Sign in

Log in through your institution

Subscribe